Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport Conversion in Cervical Dystonia
NCT06886750Phase 4Not yet recruiting
- Sponsor
- Western University
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, single-blind trial of botulinum toxin type A in cervical dystonia (CD) (2 arms), sponsored by Western University. Primary endpoint: Waning Time at 36 weeks. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT06886750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06886750.